Exicure, Inc. (XCUR)

Trade XCUR now with
2/4/2022 7:03:42 AM Exicure CEO Brian Bock Resigns
11/19/2021 7:09:31 AM Exicure Q3 Net Loss $23.5 Mln Vs. Net Loss $8.8 Mln Last Year
8/12/2021 7:20:32 AM Exicure Q2 Net Loss Widens To $14.3 Mln From $4.3 Mln Prior Year
8/5/2021 7:43:22 AM Exicure Provides Interim Results From Ongoing Phase 1b/2 Clinical Trial Of Cavrotolimod
8/2/2021 1:06:52 AM Ipsen, Exicure Enter Into Collaboration Targeting Rare Neurodegenerative Disorders
3/11/2021 8:50:05 AM Exicure FY Revenue Rises To $16.6 Mln From $1.3 Mln Prior Year
3/9/2021 8:48:00 AM Exicure Appoints Elizabeth Garofalo And Andrew Sassine To Its Board
3/3/2021 7:10:52 AM Exicure Says FDA Granted Orphan Drug Designation For Its Clinical Product Candidate, Cavrotolimod
1/11/2021 7:20:15 AM Exicure Says FDA Grants 2 Fast Track Designations For Cavrotolimod For 2 Development Programs
1/5/2021 7:08:56 AM Exicure Appoints James Sulat To Its Board